fbpx

Announcement

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

The University of Queensland (UQ) and Wesley Medical Research (WMR) have entered into a Memorandum of Understanding (MOU) to cooperate in areas of applied medical research, especially research into Infectious Diseases and Clinical Neuroscience.

On August 24, the Australian Government requested applications for funding of antibiotic resistance research via the Medical Research Future Fund.

In furtherance of the MOU, Professor David Paterson will be going on leave from WMR from 4 October to work on these applications, to be the Director of the University of Queensland Centre for Clinical Research (UQCCR), and to establish the Asia Pacific Collaboration on Antibiotic Resistance Research based at UQCCR.

While on leave, David will be available to WMR. During his leave, Dr John Allan will act as the CEO of WMR.

 

For more information or queries:

Please contact Kate Heffernan on 0426 708 668

More to explore...

[Video] Panel Pledge Live

On June 18th 2020, Wesley Medical Research and its world-renowned local research leadership team pledged its support to the global medical community, to fast track answers to combat COVID-19, at the official opening of the COVID-19 Rapid Response Research Centre.

Read More »

COVID-19 Rapid Response Research Centre Launch and Researcher Panel Pledge Live

This event will feature a live panel discussion facilitated by Professor Ian Frazer, leading researcher and immunologist, in conversation with our world-renowned local research leadership team. At this event, you will hear the latest findings and insights into our key research methodologies that provide a holistic framework to benefit those on the frontline; those who are critically ill; those with pre-existing conditions and those vulnerable to mental health concerns.

Read More »

Wesley Medical Research

Scroll to Top